• Filing Date: 2019-05-14
  • Form Type: 10-Q/A
  • Description: Quarterly report (Amendment)
v3.19.1
STATEMENTS OF CASH FLOWS - USD ($)
6 Months Ended
Mar. 31, 2019
Mar. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (5,201,779) $ (10,895,965)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 316,083 308,259
Share-based payments for services 511,424 157,991
Equity based compensation 1,104,490 1,727,915
Common stock contributed to 401(k) plan 72,124 72,400
Shares issued for settlement of clinical research costs 1,290,000 1,247,400
Gain on derivative instruments (4,589,135) (196,585)
Amortization of debt discount 0 1,023,084
Capitalized lease interest 64,432 83,564
(Increase)/decrease in assets:    
Receivables (4,579) 81,698
Prepaid expenses (74,741) 42,748
Inventory used for R&D and manufacturing (115,774) 42,211
Deposits 0 150,000
Increase/(decrease) in liabilities:    
Accounts payable (1,489,234) (541,767)
Accrued expenses 82,580 (33,966)
Due to employees 245,074 360,972
Other liabilities (1,057) 2,638
Net cash used in operating activities (7,790,092) (6,367,403)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of equipment (160,920) 0
Expenditures for patent costs (67,661) (1,113)
Net cash used in investing activities (228,581) (1,113)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of common stock and warrants 0 7,127,141
Payments of stock issuance costs (80,224) (62,004)
Proceeds from exercise of warrants 3,305,387 0
Payments on obligations under capital lease (2,521) (3,870)
Net cash provided by financing activities 3,222,642 7,061,267
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (4,796,031) 692,751
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 10,310,044 2,369,438
CASH AND CASH EQUIVALENTS, END OF PERIOD 5,514,013 3,062,189
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Capitalizable patent costs included in accounts payable 0 8,137
Capital lease obligation included in accounts payable 428 402
Stock issuance costs included in accounts payable 10,000 68,374
Prepaid consulting services paid with issuance of common stock (83,415) 95,911
Notes payable converted into common shares 0 184,300
Cash paid for interest expense $ 902,091 $ 872,087